These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18165968)

  • 1. Identification of pharmacogenetic markers in smoking cessation therapy.
    Heitjan DF; Guo M; Ray R; Wileyto EP; Epstein LH; Lerman C
    Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):712-9. PubMed ID: 18165968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy.
    Sarginson JE; Killen JD; Lazzeroni LC; Fortmann SP; Ryan HS; Schatzberg AF; Murphy GM
    Am J Med Genet B Neuropsychiatr Genet; 2011 Apr; 156B(3):275-84. PubMed ID: 21268243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.
    Tomaz PRX; Santos JR; Scholz J; Abe TO; Gaya PV; Negrão AB; Krieger JE; Pereira AC; Santos PCJL
    BMC Med Genet; 2018 Apr; 19(1):55. PubMed ID: 29621993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.
    Lee AM; Jepson C; Hoffmann E; Epstein L; Hawk LW; Lerman C; Tyndale RF
    Biol Psychiatry; 2007 Sep; 62(6):635-41. PubMed ID: 17223085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence.
    Ray R; Mitra N; Baldwin D; Guo M; Patterson F; Heitjan DF; Jepson C; Wileyto EP; Wei J; Payne T; Ma JZ; Li MD; Lerman C
    Neuropsychopharmacology; 2010 May; 35(6):1374-82. PubMed ID: 20147892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies.
    Pintarelli G; Galvan A; Pozzi P; Noci S; Pasetti G; Sala F; Pastorino U; Boffi R; Colombo F
    Sci Rep; 2017 Dec; 7(1):16730. PubMed ID: 29196725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence.
    Berrettini WH; Wileyto EP; Epstein L; Restine S; Hawk L; Shields P; Niaura R; Lerman C
    Biol Psychiatry; 2007 Jan; 61(1):111-8. PubMed ID: 16876132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bupropion. An antidepressant used to help smoking cessation].
    Taeron C
    Rev Infirm; 2002 May; (81):47-9. PubMed ID: 12078615
    [No Abstract]   [Full Text] [Related]  

  • 9. A placebo controlled trial of bupropion for smoking cessation in schizophrenia.
    George TP; Vessicchio JC; Termine A; Bregartner TA; Feingold A; Rounsaville BJ; Kosten TR
    Biol Psychiatry; 2002 Jul; 52(1):53-61. PubMed ID: 12079730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The "bupropion for smoking cessation" trial from a family practice perspective.
    Caplan BJ
    Arch Intern Med; 2005 Feb; 165(4):470. PubMed ID: 15738382
    [No Abstract]   [Full Text] [Related]  

  • 11. From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation.
    Salloum NC; Buchalter ELF; Chanani S; Espejo G; Ismail MS; Laine RO; Nageeb M; Srivastava AB; Trapp N; Trillo L; Vance E; Wenzinger M; Hartz SM; David SP; Chen LS
    Pharmacogenomics; 2018 Jul; 19(10):861-871. PubMed ID: 29914292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helping smokers quit through pharmacogenetics.
    Lerman C
    LDI Issue Brief; 2006; 11(6):1-4. PubMed ID: 16827222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.
    Lerman C; Jepson C; Wileyto EP; Epstein LH; Rukstalis M; Patterson F; Kaufmann V; Restine S; Hawk L; Niaura R; Berrettini W
    Neuropsychopharmacology; 2006 Jan; 31(1):231-42. PubMed ID: 16123753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplicity-calibrated Bayesian hypothesis tests.
    Guo M; Heitjan DF
    Biostatistics; 2010 Jul; 11(3):473-83. PubMed ID: 20212321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking cessation interventions for smokers with current or past depression.
    van der Meer RM; Willemsen MC; Smit F; Cuijpers P
    Cochrane Database Syst Rev; 2013 Aug; (8):CD006102. PubMed ID: 23963776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
    Simon JA; Duncan C; Huggins J; Solkowitz S; Carmody TP
    Nicotine Tob Res; 2009 Jun; 11(6):663-9. PubMed ID: 19395688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for smoking cessation and reduction in individuals with schizophrenia.
    Tsoi DT; Porwal M; Webster AC
    Cochrane Database Syst Rev; 2010 Jun; (6):CD007253. PubMed ID: 20556777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bupropion and cognitive-behavioral treatment for depression in smoking cessation.
    Brown RA; Niaura R; Lloyd-Richardson EE; Strong DR; Kahler CW; Abrantes AM; Abrams D; Miller IW
    Nicotine Tob Res; 2007 Jul; 9(7):721-30. PubMed ID: 17577801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers.
    Zhu AZ; Zhou Q; Cox LS; David SP; Ahluwalia JS; Benowitz NL; Tyndale RF
    Clin Pharmacol Ther; 2014 Aug; 96(2):256-65. PubMed ID: 24733007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SNPs in NRXN1 and CHRNA5 are associated to smoking and regulation of GABAergic and glutamatergic pathways.
    Pérez-Rubio G; Pérez-Rodríguez ME; Fernández-López JC; Ramírez-Venegas A; García-Colunga J; Ávila-Moreno F; Camarena A; Sansores RH; Falfán-Valencia R
    Pharmacogenomics; 2016 Jul; 17(10):1145-1158. PubMed ID: 27355804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.